Clinical Trial: Neostigmine Treatment of Acute Pancreatitis Combined With Intra-abdominal Hypertension

Study Status: Not yet recruiting
Recruit Status: Not yet recruiting
Study Type: Interventional




Official Title: The Curative Effect and Security of Neostigmine Treatment of Acute Pancreatitis Combined With Intra-abdominal Hypertension

Brief Summary: Acute pancreatitis with Intra-abdominal Hypertension have high mortality rate, intra-abdominal pressure mainly because of intestinal paralysis which due to edema, intestinal gas, fluid and other intestinal dysfunction.Neostigmine is an anti-cholinesterase drugs, can enhance intestinal peristalsis, promote flatus, defecation. This study will determine the efficacy of neostigmine in the treatment of acute pancreatitis with Intra-abdominal Hypertension.